title: Active immunization by a dengue virus-induced cytokine.
abstract: Dengue type 2 virus (DV)-induced cytotoxic factor (CF) is capable of reproducing various pathological lesions in mice that are seen in human dengue. The present study was undertaken to investigate the protective effect of active immunization of mice with CF. Mice were immunized with 5 microgram of CF and prevention of CF-induced increase in capillary permeability and damage to the blood-brain barrier were studied at weekly intervals, up to 48 weeks, by challenging with 3 microgram of CF. Maximum protection against increase in capillary permeability and damage to the blood-brain barrier was observed in week 4 after immunization. A breakthrough in the protection occurred with higher doses of CF in a dose-dependent manner. Challenge with a lethal intracerebral (i.c.) dose of DV showed significantly prolonged mean survival time and delayed onset of symptoms of sickness in the immunized mice compared with the normal mice, but the titre of the virus in the brain was similar in the two groups. On i.p. challenge with the virus the protection against damage to the blood-brain barrier was 86 +/- 7% at week 4 and 17 +/- 4% at week 26 after immunization. Sera obtained from the immunized mice showed the presence of CF-specific antibodies by ELISA, Western blot, and by neutralization of the cytotoxic activity of CF in vitro. The present study describes successful prevention of a cytokine-induced pathology by specific active immunization.
authors.affiliation: Postgraduate Department of Microbiology, K.G. Medical College, Lucknow, India.
authors.forename: U C
authors.initials: UC
authors.lastname: Chaturvedi
authors.forename: R
authors.initials: R
authors.lastname: Mukerjee
authors.forename: R
authors.initials: R
authors.lastname: Dhawan
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain / Q000382:microbiology; D002199:Capillary Permeability; D016207:Cytokines / Q000276:immunology / Q000627:therapeutic use*; D003715:Dengue / Q000517:prevention & control*; D003716:Dengue Virus / Q000302:isolation & purification; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D007114:Immunization; D051379:Mice; D009500:Neutralization Tests
chemical_list: D016207:Cytokines; C087354:dengue-2 virus-induced cytotoxic factor